Please assess the completion status of the following clinical trial:

Trial Title: Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed Insulin

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with Type 2 Diabetes Mellitus inadequately controlled at least 3 months on premixed insulin with 1 or 2 OADs~* 7.5 ≤ HbA1c ≤ 9.5%~* FPG ≥6.7 mmol/L~* History of Diabetes mellitus ≤10 years~* Premix insulin daily dosage ≤ 50 IU/Day~Exclusion Criteria:~* Type 1 Diabetes Mellitus~* Former treated on TZD~* Pregnancy / Lactation~* Creatine ≥1.5 mg/dl~* Hepatic disease, jaundice,or ALT/AST≥ 2.5 times of normal range~* Hormone therapy,~* Acute status of Diabetes complications~* Severe concomitant disease or complications with high risk of unexpected fatal events, like Myocardial Infarct, stroke, heart failure.~* Allergic to insulin glargine or any ingredient~* Participation in another clinical trial within 3 months~The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).